Managers / Q3 2019 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Summary
Harbourvest Partners LLC reported $240M in U.S.-listed holdings across 33 positions for Q3 2019.
The portfolio is heavily concentrated: Solarwinds alone accounts for 60.4% of reported value.
Compared with Q2 2019, the fund opened 7 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.7% · $216M
- Other · 9.1% · $22M
- ADR · 1.2% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Axcella Health, Inc. | NEW | +1.23M | 1.23M | +$7M | $7M |
| Smartsheet, Inc. | NEW | +135.9K | 135.9K | +$5M | $5M |
| Spark Networks SE | NEW | +502.6K | 502.6K | +$3M | $3M |
| VCYTVeracyte, Inc. | NEW | +84.9K | 84.9K | +$2M | $2M |
| RDFNRedfin Corp. | NEW | +114.7K | 114.7K | +$2M | $2M |
| UPWKUpwork, Inc. | NEW | +34.4K | 34.4K | +$457,000 | $457,000 |
| Guardant Health, Inc. | NEW | +6.1K | 6.1K | +$386,000 | $386,000 |
| SNAPSnap, Inc. | SOLD OUT | −296.4K | 0 | −$4M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | Solarwinds Corp. | Common | 60.42% | $145M | 7.87M |
| 2 | WORKSlack Technologies, Inc.history → | Common CL A | 6.52% | $16M | 660.5K |
| 3 | Evelo Biosciences, Inc. | Common | 4.47% | $11M | 1.76M |
| 4 | KLDOKaliedo Biosciences, Inc.history → | Common | 3.66% | $9M | 1.17M |
| 5 | Finjan Holdings, Inc. | Common New | 3.60% | $9M | 4.30M |
| 6 | Rubius Therapeutics, Inc. | Common | 3.22% | $8M | 986.9K |
| 7 | Axcella Health, Inc. | Common | 2.89% | $7M | 1.23M |
| 8 | LendingClub Corp. | Common | 2.79% | $7M | 513.4K |
| 9 | Smartsheet, Inc. | Common CL A | 2.04% | $5M | 135.9K |
| 10 | Zuora, Inc. | Common | 1.42% | $3M | 226.4K |
| 11 | Spark Networks SE | Sponsored ADR | 1.16% | $3M | 502.6K |
| 12 | U.S. Auto Parts Network, Inc. | Common | 0.95% | $2M | 1.48M |
| 13 | VCYTVeracyte, Inc. | Common | 0.85% | $2M | 84.9K |
| 14 | RDFNRedfin Corp. | Common | 0.80% | $2M | 114.7K |
| 15 | INOVInovalon Holdings, Inc. | Common New | 0.78% | $2M | 113.8K |
| 16 | YEXTYext, Inc. | Common | 0.76% | $2M | 115.1K |
| 17 | NTNXNutanix, Inc. | Common CL A | 0.64% | $2M | 58.9K |
| 18 | SFIXStitchfix, Inc. | Common CL A | 0.53% | $1M | 66.6K |
| 19 | RYTMRhythm Pharmaceuticals, Inc. | Common | 0.45% | $1M | 50.2K |
| 20 | PluralSight, Inc. | Common CL A | 0.37% | $891,000 | 53.1K |
| 21 | CTMXCytomx Therapeutics, Inc. | Common | 0.24% | $584,000 | 79.2K |
| 22 | Castlight Health, Inc. | Common CL B | 0.20% | $492,000 | 349.1K |
| 23 | UPWKUpwork, Inc. | Common | 0.19% | $457,000 | 34.4K |
| 24 | ARAntero Resources LLC | Common | 0.17% | $398,000 | 131.9K |
| 25 | Guardant Health, Inc. | Common | 0.16% | $386,000 | 6.1K |
| 26 | Kala Pharmaceuticals, Inc. | Common | 0.16% | $377,000 | 99.2K |
| 27 | Proteostasis Therapeutics, Inc. | Common | 0.15% | $372,000 | 440.6K |
| 28 | Revance Therapeutics, Inc. | Common | 0.14% | $343,000 | 26.4K |
| 29 | Trevena, Inc. | Common | 0.09% | $226,000 | 233.8K |
| 30 | Epizyme, Inc. | Common | 0.06% | $145,000 | 14.1K |
| 31 | Care.com, Inc. | Common | 0.06% | $137,000 | 13.1K |
| 32 | Ramaco Resources, Inc. | Common | 0.02% | $56,000 | 15.0K |
| 33 | HNRGHallador Energy Resources, Inc. | Common | 0.02% | $52,000 | 14.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.